Rizvi N, et al. Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial. Abstract OA04.07. WCLC 2019, 7-10 september, Barcelona, Spanje.
Analyse van circulerend tumor-DNA bij patiënten met ‘ALK’-positieve longkanker
dec 2019 | Longoncologie